おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Pro-Cure Therapeutics
company
About
Pro-Cure Therapeutics is focused on developing drugs targeted against cancer stem cells.
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $1.08M
- Industries
- Biotechnology,Health Diagnostics,Medical,Pharmaceutical
- Founded date
- Jan 1, 2001
- Operating Status
- Active
Pro-Cure Therapeutics Limited is focused on developing drugs targeted against cancer stem cells. The company has identified targets for new classes of cancer drugs that may fundamentally change the management of cancer. They are developing a pipeline of therapeutic candidates against these targets, starting in prostate cancer and then expanding into other tumour types.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.08M
Pro-Cure Therapeutics has raised a total of
$1.08M
in funding over 2 rounds. Their latest funding was raised on
Apr 13, 2010 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 13, 2010 | Series Unknown | $1.08M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Pro-Cure Therapeutics is funded by 1 investors.
SMH Venture Finance Limited
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
SMH Venture Finance Limited
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
